Advances in the Antibody Drug Development Workflow

Partnering with a single CDMO can increase speed to market, ensure production capacity and avoid costly-time consuming tech transfers. Learn more inside this eBook.

Antibody-based drug discovery at the speed of light

The combination of the PentaMice® platform and single B cell screening with the Beacon® system increases speed to market for monoclonal antibody antibody therapeutics.